A significant interaction between cerebrospinal fluid (CSF) Aβ, phospho‐tau biomarkers and cross‐sectional cortical thickness in preclinical AD was observed by Fortea et al. (2014), but they did not report a significant thickness difference between Aβ+ and Aβ− groups. Here, MAPT is linked to Alzheimer disease.